Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
While the peptide demonstrated a favorable safety profile, its development as a prescription obesity medication was discontinued in 2007 after mixed efficacy results in larger trials
You might not have added enough water
Last reviewed: May 31, 2026 Last updated: May 31, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Both peptides show activity in GI healing research, but through completely different mechanisms
Hypokalemia Risk: Intense treatment of severe anemia can cause a sudden drop in blood potassium levels
US$ 29.38
US$ 22.87
US$ 27.42
US$ 20.45
US$ 21.77
